Mawby W J, Findlay J B
Biochem J. 1982 Sep 1;205(3):465-75. doi: 10.1042/bj2050465.
We investigated the presumed anion-binding domain of the anion-transport protein from human erythrocyte membranes, using 2,6-di-iodo-4-sulphophenyl isothiocyanate, an inhibitor of anion transport. The 125I-labelled reagent binds covalently to the protein with a half-maximal inhibitory concentration of 86 microM. Treatment of unsealed erythrocyte 'ghosts' with chymotrypsin yielded a membrane-bound fragment (mol.wt. 14 500 +/- 1000) that contained all the protein-bound radioactivity. The binding of the inhibitor to this peptide gave a pattern very similar to that obtained for the effect of the compound on phosphate transport into erythrocytes. The peptide is therefore presumed to be intimately involved in the mediation of anion exchange. Cleavage of the 14 500-mol.wt. transmembrane fragment with CNBr resulted in the production of two peptides with apparent molecular weights of 8800 and 4700. The 4700-mol.wt. peptide is the N-terminal portion of the 14 500-mol.wt. peptide. The attachment site for 2,6-di-iodo-4-sulphophenyl isothiocyanate is situated near the C-terminal of the 8800-mol.wt. peptide. This locates the inhibitor-binding site near the chymotrypsin cleavage point at the extracellular surface of the membrane. A partial sequence (residues 1--38) of the 8800-mol.wt. peptide was obtained.
我们使用阴离子转运抑制剂2,6 - 二碘 - 4 - 磺基苯基异硫氰酸酯,对人红细胞膜阴离子转运蛋白的假定阴离子结合结构域进行了研究。125I标记的该试剂与蛋白质共价结合,其半数抑制浓度为86微摩尔。用胰凝乳蛋白酶处理未封闭的红细胞“血影”,得到一个膜结合片段(分子量14500±1000),该片段含有所有与蛋白质结合的放射性。抑制剂与该肽段的结合模式与该化合物对磷酸盐转运进入红细胞的作用模式非常相似。因此推测该肽段与阴离子交换的介导密切相关。用溴化氰切割分子量为14500的跨膜片段,产生了两个表观分子量分别为8800和4700的肽段。分子量为4700的肽段是分子量为14500肽段的N端部分。2,6 - 二碘 - 4 - 磺基苯基异硫氰酸酯的附着位点位于分子量为8800肽段的C端附近。这将抑制剂结合位点定位在膜细胞外表面胰凝乳蛋白酶切割点附近。获得了分子量为8800肽段的部分序列(第1 - 38位氨基酸残基)。